Posted on: 28 March, 2017
New York— Evidence continues to accumulate that clomiphene citrate (Clomid), approved in the U.S. for the treatment of ovulatory dysfunction in women, may be an effective therapeutic option for men with hypogonadism.
Read More
Read more